| Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
|---|
| 03/17/2005 | WO2004096120A3 Compounds that selectively bind to membranes of apoptotic cells |
| 03/17/2005 | WO2003084305A8 Trihydroxy polyunsaturated eicosanoids |
| 03/17/2005 | CA2537252A1 Cyclohexyl prostaglandin analogs as ep4-receptor agonists |
| 03/16/2005 | EP1513526A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators |
| 03/16/2005 | EP1163200B9 Method of industrial-scale purification of lactic acid |
| 03/16/2005 | CN1594266A Method for recovering 2-keto-L-gluconic acid from gluconic acid crystallization mother liquor |
| 03/16/2005 | CN1594265A Preparation method of gluconic acid and its salt |
| 03/16/2005 | CN1593839A Novel purpose of 4-(4-methyl-n-amyl)-cyclohexane-1, 2-dicarboxylic acid |
| 03/16/2005 | CN1593838A Novel purpose of 4-(4-methyl-3-pentenyl)-4-cyclohexene-1, 2-dicarboxylic acid |
| 03/15/2005 | US6867320 Prostaglandin inhibitor; suppression leukotriene; antiinflammatory agents; rheumatic diseases |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867218 An arylene or heteroarylene alkoxy or hydroxy-propionic acid or ester derivatives; treatment or prevention of Peroxisome Proliferator-Activated Receptors; diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 03/10/2005 | WO2005021479A1 Benzotropolone derivatives and modulation of inflammatory response |
| 03/10/2005 | US20050054877 Enantiomerically selective cyclopropanation |
| 03/10/2005 | US20050054727 For treating or delaying progression or onset of obesity, hypercholesterolemia, atherosclerosis, depression, osteoporosis, hypothyroidism, non-toxic goiter, reduced bone mass, density or growth, eating disorders, cardiac arrhythmia |
| 03/10/2005 | US20050054632 Naphthyl compounds, intermediates, compositions, and methods of use |
| 03/10/2005 | CA2536842A1 Benzotropolone derivatives and modulation of inflammatory response |
| 03/09/2005 | EP1511736A1 Therapeutic molecules and methods-1 |
| 03/09/2005 | EP1511490A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 03/09/2005 | CN1592730A Method for the purification of an alpha-hydroxy acid on an industrial scale |
| 03/09/2005 | CN1592726A Optical dividing method for sclare lactone precursor |
| 03/09/2005 | CN1590357A Lightfast additive having uv-absorbing moiety and ink composition including the same |
| 03/08/2005 | US6863211 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 03/03/2005 | WO2005019151A1 Ppar modulators |
| 03/03/2005 | WO2005000784A3 5-[phenyl, tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl- cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity |
| 03/03/2005 | WO2003089418A8 Indane acetic acid derivatives and their use as pharmaceutical agents |
| 03/03/2005 | US20050049418 such as 3-benzyl-1-methoxy-4,5-dimethylimidazolium iodide; by-product inhibition; for recycling polyesters and polyamides |
| 03/03/2005 | US20050049284 therapeutic and preventive agents for scavenging free radicals and for inflammatory conditions; show a high safety even in a long-term administration and used as part of food, beverage and/or cosmetic products that are used daily; Neotheaflavate B; EGCGCa ( Epigallocatechinocatechol gallate ) |
| 03/03/2005 | US20050049227 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
| 03/03/2005 | US20050048024 Compounds for use as surfactants |
| 03/03/2005 | CA2536089A1 Ppar modulators |
| 03/02/2005 | EP1509216A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | CN1587248A Process for synthesizing 7-chloro-2-oxo-heptanoic acid |
| 03/02/2005 | CN1587247A Process for directly producing calcium lactate from crust and lactic acid |
| 03/02/2005 | CN1191226C Preparing method of perfluorinated acid fluorides |
| 03/02/2005 | CN1191225C Purification of aqueous solutions of organic acids |
| 03/01/2005 | US6861555 Crystaline alcohol and water solvates of 6-(5-carboxy-5-methyl-hexyloxy)-2, 2-dimethylhexonoic acid monocalcium salt; treating dyslipidemia |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | US20050043278 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/23/2005 | EP1507523A1 Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease |
| 02/23/2005 | EP1053220B1 Improved separation processes |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/23/2005 | CN1585630A Method for the formation of ibuprofen crystals |
| 02/22/2005 | US6858761 Process for preserving resin catalyst for addition reaction of alkylene oxide and utilization of this process |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/22/2005 | US6858600 Used for inhibiting the interaction of an alpha-helical protein with another protein or binding site; for therapy of diseases |
| 02/17/2005 | WO2005014521A1 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes |
| 02/17/2005 | WO2004067489A8 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 02/17/2005 | US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol |
| 02/17/2005 | US20050038123 Process and intermediates to prepare latanoprost |
| 02/17/2005 | US20050038122 Phenyl naphthol ligands for thyroid hormone receptor |
| 02/17/2005 | US20050038119 for treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis; prevention and treatment of damages caused by ischemia and reperfusion |
| 02/16/2005 | EP1506951A1 Preparation and application of transhintotalphenolic acid |
| 02/16/2005 | EP1425258A4 Hydroxyeicosenoic acid analogs |
| 02/16/2005 | EP1064285B1 Novel cephalotaxane derivatives and process for their preparation |
| 02/16/2005 | EP0870052B1 Process for the preparation of gluconic acid and gluconic acid produced thereby |
| 02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/10/2005 | WO2005012233A1 Meldonium salts, method of their preparation and pharmaceutical composition on their basis |
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
| 02/10/2005 | US20050032902 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
| 02/09/2005 | EP1436252A4 Hydroxyfattysulfonic acid analogs |
| 02/09/2005 | EP1294705A4 Synthesis of cyclic compounds |
| 02/08/2005 | US6852884 Process for preparing acylfluorides |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/03/2005 | WO2005009104A2 Benzoic and phenyl acetic acid derivatives as hnf-4 modulators |
| 02/03/2005 | WO2004091278A3 Gabapentin compositions |
| 02/03/2005 | US20050027044 Process of making press molded materials using heat activated tertiary amine urethane catalysts |
| 02/03/2005 | US20050027037 Addition-condensation copolymers of polyethers modified by a hydroxycarboxylic acid or ester and a hydroxyethyl vinyl ether as well as addition polymers of unsaturated oxy carboxylic acids or esters used as inks and toners for ink jet printers; improved dispersibility and stability of coloring materials |
| 02/03/2005 | US20050027002 Heat activated tertiary amine urethane catalysts |
| 02/02/2005 | EP1502909A1 Use of a dihydrojasmonic acid derivative as a desquamative agent |
| 02/01/2005 | US6849762 Process for preparing a trifluoroethoxy-substituted benzoic acid |
| 02/01/2005 | CA2362698C Resorcinol derivatives |
| 01/27/2005 | US20050020855 Process for producing a fluorine-containing compound by liquid phase fluorination |
| 01/27/2005 | US20050020854 For use as cleaning and foaming agents and as emulsifiers |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020680 Hydroxyfattysulfonic acid analogs |
| 01/27/2005 | CA2851309A1 Compounds and methods for delivery of prostacyclin analogs |
| 01/27/2005 | CA2736406A1 Compositions comprising diethanolamine salts of trepostinil in the treatment of pulmonary hypertension and other cardiovascular diseases |
| 01/26/2005 | EP1499578A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 01/26/2005 | CN1571766A Novel compounds, their preparation and use |
| 01/26/2005 | CN1569803A Process for preparing aryl beta-diketo acid |
| 01/26/2005 | CN1186308C Preparation method for ammonium citrate |
| 01/20/2005 | WO2005005366A1 Branched carboxylic acid compound and use thereof |
| 01/19/2005 | EP1498405A1 Liquid vegetable unsaturated alcohol and process for producing the same |
| 01/19/2005 | EP1497271A1 Indane acetic acid derivatives and their use as pharmaceutical agents |
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 01/19/2005 | CN1566141A Process for production of aspartame derivative, crystal thereof, novel production intermediate therefor, and process for production of intermediate thereof |
| 01/19/2005 | CN1566065A Alpha position heteroatom substituted gamma aryl ketobutyric acid derivative, process, pharmaceutical combination and uses thereof |
| 01/18/2005 | US6844467 Saponification of corresponding nitrile or ester compound; chemical intermediates |
| 01/13/2005 | WO2005003076A1 Novel heptatrienoic acid substitued bicyclic ketone derivative and pharmaceutical compositions comprising the same |
| 01/13/2005 | WO2005003075A1 Fluoroalkyl carboxylic acid derivative, method for producing fluorine-containing polymer, and aqueous dispersion of fluorine-containing polymer |
| 01/13/2005 | US20050009909 Carboxylic compound and medicine comprising the same |
| 01/12/2005 | EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 01/12/2005 | EP1494993A2 Novel curcumin analogues and uses thereof |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494988A1 A method of making salt |